These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 399639)
41. The value of dexamethasone when added to combination drug therapy in the prevention of cisplatin-induced nausea and vomiting, evaluated by time-lapse video technology. Rhinehart SN; Dugan WM; Parashos PJ; Triplett WC; Minnick DJ; Fry MW Prog Clin Biol Res; 1986; 216():407-16. PubMed ID: 3523534 [No Abstract] [Full Text] [Related]
42. A randomized study evaluating radiotherapy versus chemotherapy in patients with inoperable non-small cell lung cancer. Bull CA; Langlands AO; Tiver KW Radiother Oncol; 1988 Aug; 12(4):339, 341-2. PubMed ID: 2847253 [No Abstract] [Full Text] [Related]
44. A randomized trial of metoclopramide and a combination of dexamethasone and lorazepam for prevention of chemotherapy-induced vomiting. Gagen M; Gochnour D; Young D; Gaginella T; Neidhart J J Clin Oncol; 1984 Jun; 2(6):696-701. PubMed ID: 6374059 [TBL] [Abstract][Full Text] [Related]
46. Practical experience of randomization in cancer trials: an international survey. Pocock SJ; Lagakos SW Br J Cancer; 1982 Sep; 46(3):368-75. PubMed ID: 7126426 [TBL] [Abstract][Full Text] [Related]
47. Intracavitary adriamycin nitrogen mustard and tetracycline in the control of malignant effusions: a randomized study. Kefford RF; Woods RL; Fox RM; Tatterall MH Med J Aust; 1980 Oct; 2(8):447-8. PubMed ID: 7010099 [No Abstract] [Full Text] [Related]
48. Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine. Sallan SE; Cronin C; Zelen M; Zinberg NE N Engl J Med; 1980 Jan; 302(3):135-8. PubMed ID: 6985702 [TBL] [Abstract][Full Text] [Related]
49. Behavioral treatment for the anticipatory nausea and vomiting induced by cancer chemotherapy. Morrow GR; Morrell C N Engl J Med; 1982 Dec; 307(24):1476-80. PubMed ID: 6128673 [TBL] [Abstract][Full Text] [Related]
50. Knowledge acquisition in oncology from randomized therapeutic trials. Flamant R; Sancho-Garnier H Bull Cancer; 1980; 67(4):446-9. PubMed ID: 7225601 [TBL] [Abstract][Full Text] [Related]
51. [A tentative of guideline for phase III study and its problems in clinical aspect]. Nakao I Gan To Kagaku Ryoho; 1984 Mar; 11(3):395-403. PubMed ID: 6703719 [TBL] [Abstract][Full Text] [Related]
52. Chemotherapy for stomach cancer. Clark PI; Slevin ML Br Med J (Clin Res Ed); 1987 Oct; 295(6603):870-1. PubMed ID: 3119080 [No Abstract] [Full Text] [Related]
57. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cuzick J; Stewart H; Peto R; Baum M; Fisher B; Host H; Lythgoe JP; Ribeiro G; Scheurlen H; Wallgren A Cancer Treat Rep; 1987 Jan; 71(1):15-29. PubMed ID: 2856861 [TBL] [Abstract][Full Text] [Related]
58. Ineffectiveness of droperidol as antiemetic. Jackson M; Bozzino J; Prasad V; Warenius H Drug Intell Clin Pharm; 1985 Nov; 19(11):841-2. PubMed ID: 3905322 [No Abstract] [Full Text] [Related]
59. Chlorpromazine and dexamethasone versus high-dose metoclopramide and dexamethasone in patients receiving cancer chemotherapy, particularly cis-platinum: a prospective randomized crossover study. Gez E; Ben-Yosef R; Catane R; Brufman G; Biran S Oncology; 1989; 46(3):150-4. PubMed ID: 2654792 [TBL] [Abstract][Full Text] [Related]
60. Patients' preferences in randomized clinical trials. Angell M N Engl J Med; 1984 May; 310(21):1385-7. PubMed ID: 6717511 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]